{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:54:17Z","timestamp":1782528857361,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ygyno.2013.01.029","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T19:32:35Z","timestamp":1360006355000},"page":"364-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy"],"prefix":"10.1016","volume":"129","author":[{"given":"C.B.","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Cass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"McLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.Y.","family":"Karlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.01.029_bb0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","article-title":"Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"91","author":"Stratton","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 1:S1","key":"10.1016\/j.ygyno.2013.01.029_bb0025","article-title":"International Conference on Ovarian Cancer Screening: 29th\u201330th November 2011, Royal College of Physicians, London. Foreword","volume":"22","author":"Menon","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0030","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0035","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I","article-title":"Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations","volume":"86","author":"Deligdisch","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0045","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0050","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mpdhp.2008.06.009","article-title":"Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube","volume":"14","author":"Carlson","year":"2008","journal-title":"Diagn Histopathol (Oxf)"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0090","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0100","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/GCO.0b013e32801195da","article-title":"Prophylactic oophorectomy in women at increased cancer risk","volume":"19","author":"Domchek","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0115","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0120","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2004.10.017","article-title":"Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense?","volume":"96","author":"Olivier","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1016\/j.ygyno.2013.01.029_bb0130","first-page":"e1","article-title":"Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1\/2 mutation carriers?","volume":"204","author":"Greene","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2007.11.6905","article-title":"Effect of BRCA1\/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer","volume":"26","author":"Chetrit","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0140","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/gyno.2002.6638","article-title":"Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy","volume":"85","author":"Colgan","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0155","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/01.pas.0000131554.05732.cd","article-title":"Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations","volume":"28","author":"Agoff","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0165","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical\u2013pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0175","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","article-title":"Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature","volume":"30","author":"Carcangiu","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0180","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ygyno.2012.03.009","article-title":"Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility","volume":"125","author":"Landon","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2011.10.017","article-title":"The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian\/tubal cancer","volume":"124","author":"Manchanda","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the \u201cfallopian tube hypothesis\u201d in a prospective series of risk-reducing salpingo-oophrectomy specimens","volume":"49","author":"Reitsma","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0195","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case\u2013control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.029_bb0200","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:33:51Z","timestamp":1758771231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0090825813000668"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.029","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}